Three immune signaling pathways, including JAK-STAT, NF-κB, and TNF signaling pathways, are conspicuously augmented in the primary tumor sites of HRD cancers, which might imply the origin of the immune signal of HRD tumor cells. This evidence concerns the gene TNF and hypoparathyroidism-retardation-dysmorphism syndrome.